# Carvedilol Post-intervention Long-term Administration in Large-scale Trial

Study · id `cardio:ct-nct01155635` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01155635](<https://clinicaltrials.gov/study/NCT01155635>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01155635

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 801 participants.

## Technical summary

Registry record NCT01155635. Randomized; single masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2015-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 801 participants (enrolled count; ClinicalTrials.gov record NCT01155635, source copy `cardio:ctgov-nct01155635-2017-06-27`, retrieved 2026-10-26)
- Start date: 2010-07 (registry gives no type) (ClinicalTrials.gov record NCT01155635, source copy `cardio:ctgov-nct01155635-2017-06-27`, retrieved 2026-10-26)
- Primary completion: 2015-06 (actual) (ClinicalTrials.gov record NCT01155635, source copy `cardio:ctgov-nct01155635-2017-06-27`, retrieved 2026-10-26)
- Completion: 2017-03 (actual) (ClinicalTrials.gov record NCT01155635, source copy `cardio:ctgov-nct01155635-2017-06-27`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT01155635, source copy `cardio:ctgov-nct01155635-2017-06-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01155635-2017-06-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Carvedilol Post-intervention Long-term Administration in Large-scale Trial
- Acronym: CAPITAL-RCT
- Condition: Myocardial Infarction
- Intervention (Drug): Carvedilol
- Intervention (Drug): No Carvedilol
- Lead sponsor: Takeshi Morimoto
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry intervention name matches this record: Carvedilol (`cardio:carvedilol`)
- Registry intervention is a member of this class by a sourced record link: Beta-blockers (drug class) (`cardio:beta-blockers`)
- Registry lists this organization as the lead sponsor: Takeshi Morimoto (`cardio:org-takeshi-morimoto`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention (`cardio:pubmed-30153268`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Long-Term Carvedilol Therapy in Patients With ST-Segment Elevation Myocardial Infarction and Mildly Reduced Left Ventricular Ejection Fraction (`cardio:pubmed-37245250`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0cc2123482c2f9d52b32315ed30b310d9443d804e1f38798dd3504512b5e1aa5
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
